Company / Current Assets per Share
IOVANCE BIOTHERAPEUTICS, INC. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.45
FY2025
5-year range
$1.45 / $3311.19
FY2021-FY2025
Trend
-18.7%
vs FY2024
Sector context
#186 of 210
Health Care
What the data says
IOVANCE BIOTHERAPEUTICS, INC.'s current assets per share of $1.45 is lower than 89% of companies in the Health Care sector (FY2025). Current Assets per Share has fluctuated over the past 10 years, ranging from $1.45 in FY2025 to $4599.39 in FY2020.
Based on SEC 10-K filings.
1.45 in FY2025 with a 5-year CAGR of -80.1%.
Declined from $1.64 to $1.45 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -92.2%
- 5-Year CAGR
- -80.1%
- 10-Year CAGR
- -
Sector benchmark
-98.9% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 18.7% year-over-year.
- Ranks #186 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.45 | -18.7% |
| FY2024 | $1.78 | +8.9% |
| FY2023 | $1.64 | -99.9% |
| FY2022 | $3008.41 | -9.1% |
| FY2021 | $3311.19 | -28.0% |
| FY2020 | $4599.39 | +80.7% |
| FY2019 | $2545.47 | +39077.3% |
| FY2018 | $6.50 | +170.9% |
| FY2017 | $2.40 | -31.3% |
| FY2016 | $3.49 | +13.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026